Vaccinex awards stock options and raises base salaries for top executives

VACCINEX, INC.

CEO Maurice Zauderer receives option for 56,000 shares at 110% of FMV, vesting over 4 years, 5-year expiry.
CSO Ernest Smith receives option for 40,000 shares; CFO Scott Royer receives option for 32,000 shares; vesting 4 years, 10-year expiry.
Base salaries increased 5% effective April 1: CEO $426,930, CSO $302,380, CFO $275,334.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.